Your browser doesn't support javascript.
loading
Selective optogenetic control of Gq signaling using human Neuropsin.
Wagdi, Ahmed; Malan, Daniela; Sathyanarayanan, Udhayabhaskar; Beauchamp, Janosch S; Vogt, Markus; Zipf, David; Beiert, Thomas; Mansuroglu, Berivan; Dusend, Vanessa; Meininghaus, Mark; Schneider, Linn; Kalthof, Bernd; Wiegert, J Simon; König, Gabriele M; Kostenis, Evi; Patejdl, Robert; Sasse, Philipp; Bruegmann, Tobias.
Afiliação
  • Wagdi A; Institute for Cardiovascular Physiology, University Medical Center Göttingen, Göttingen, Germany.
  • Malan D; German Center for Cardiovascular Research (DZHK), Partner site Göttingen, Göttingen, Germany.
  • Sathyanarayanan U; Department of Cardiology and Pulmonology, University Medical Center Göttingen, Georg August University of Göttingen, Göttingen, Germany.
  • Beauchamp JS; Institute of Physiology I, Medical Faculty, University of Bonn, Bonn, Germany.
  • Vogt M; Institute for Cardiovascular Physiology, University Medical Center Göttingen, Göttingen, Germany.
  • Zipf D; Institute for Cardiovascular Physiology, University Medical Center Göttingen, Göttingen, Germany.
  • Beiert T; Institute for Cardiovascular Physiology, University Medical Center Göttingen, Göttingen, Germany.
  • Mansuroglu B; Institute for Cardiovascular Physiology, University Medical Center Göttingen, Göttingen, Germany.
  • Dusend V; Department of Internal Medicine II, University Hospital Bonn, University of Bonn, Bonn, Germany.
  • Meininghaus M; Institute of Physiology I, Medical Faculty, University of Bonn, Bonn, Germany.
  • Schneider L; Research Training Group 1873, University of Bonn, Bonn, Germany.
  • Kalthof B; Institute of Physiology I, Medical Faculty, University of Bonn, Bonn, Germany.
  • Wiegert JS; Research Training Group 1873, University of Bonn, Bonn, Germany.
  • König GM; Bayer AG, Research & Development, Pharmaceuticals, 42096, Wuppertal, Germany.
  • Kostenis E; Bayer AG, Research & Development, Pharmaceuticals, 42096, Wuppertal, Germany.
  • Patejdl R; Bayer AG, Research & Development, Pharmaceuticals, 42096, Wuppertal, Germany.
  • Sasse P; Center for Molecular Neurobiology Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Bruegmann T; Molecular, Cellular and Pharmacobiology Section, Institute of Pharmaceutical Biology, University of Bonn, Bonn, Germany.
Nat Commun ; 13(1): 1765, 2022 04 01.
Article em En | MEDLINE | ID: mdl-35365606
ABSTRACT
Gq proteins are universally important for signal transduction in mammalian cells. The underlying kinetics and transformation from extracellular stimuli into intracellular signaling, however could not be investigated in detail so far. Here we present the human Neuropsin (hOPN5) for specific and repetitive manipulation of Gq signaling in vitro and in vivo with high spatio-temporal resolution. Properties and G protein specificity of hOPN5 are characterized by UV light induced IP3 generation, Ca2+ transients and inhibition of GIRK channel activity in HEK cells. In adult hearts from a transgenic animal model, light increases the spontaneous beating rate. In addition, we demonstrate light induced contractions in the small intestine, which are not detectable after pharmacological Gq protein block. All-optical high-throughput screening for TRPC6 inhibitors is more specific and sensitive than conventional pharmacological screening. Thus, we demonstrate specific Gq signaling of hOPN5 and unveil its potential for optogenetic applications.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transdução de Sinais / Optogenética Limite: Animals / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transdução de Sinais / Optogenética Limite: Animals / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article